INSPECS Group Names Robert Brodie as CFO, Succeeding Chris Kay in Autumn 2026

Robert Brodie Joins INSPECS as CFO: Extensive Finance Leadership in Manufacturing and Product-Focused Firms

Robert Benjamin Nathaniel Brodie, 51, joins INSPECS Group from City Energy Network where he served as Chief Financial Officer. Prior to that, he was CFO at Steripack Group, an international designer and manufacturer of medical and pharmaceutical products, providing him with relevant experience for INSPECS's vertically integrated business model. His earlier roles include CFO of Direct Healthcare Group and senior finance positions at Crown Cork & Seal, a leading packaging manufacturer. Brodie began his career at Ernst & Young, gaining foundational audit and advisory expertise before moving into executive finance roles.

Holding the Chartered Management Accountant (ACMA) qualification, Brodie brings broad expertise in finance leadership, business integration, mergers and acquisitions, and international operations. Given INSPECS's growth through acquisitions and multi-geographic integration, his skills are highly pertinent. Brodie is set to join the Group in Autumn 2026, with a transition period following the announcement dated 16 July 2026. Financial terms of his appointment were not disclosed.

Chris Kay to Support CFO Transition as Consultant at INSPECS

Chris Kay, the outgoing CFO, will remain with INSPECS on a consultancy basis after Brodie's arrival to facilitate an orderly handover. Such arrangements are common in AIM-listed companies and reassure investors of a smooth transition without disruption to financial reporting or lender relations. The duration and financial details of Kay's consultancy were not specified.

CEO Richard Peck expressed gratitude for Kay's support during the succession, indicating the search was planned and collaborative. Chair Robin Totterman emphasized the thorough search process preceding Brodie's appointment, underscoring the Board's deliberate approach to leadership change. This continuity is reassuring given INSPECS's complex global operations.

INSPECS Group’s Global Eyewear Operations Spanning 80+ Countries and Multiple Manufacturing Sites

INSPECS Group is a leading global eyewear provider, manufacturing a wide range of optical frames, sunglasses, and safety eyewear. The Group operates two main commercial channels: a "Branded" channel featuring licensed and proprietary brands, and an "OEM" channel producing private-label products for retailers. This dual approach serves diverse customers including global retailers, independent opticians, and distributors.

Geographically, INSPECS maintains offices and subsidiaries in the UK, Germany, Portugal, Scandinavia, the US, and China (including Hong Kong, Macau, and Shenzhen). Manufacturing facilities are located in Vietnam, China, the UK, and Italy. Its distribution network spans over 80 countries and approximately 75,000 points of sale, highlighting the critical role of the CFO in managing currency risks, multi-jurisdictional reporting, and financial integration across a broad footprint. Brodie’s international operations experience aligns well with these demands.

Strategic Focus for Brodie at INSPECS: Enhancing Own-Brand Growth, Innovation, and Shareholder Value

Robert Brodie highlighted INSPECS's strong brand portfolio, customer relationships, and talented global team as a solid foundation for pursuing strategic goals. He emphasized product innovation, new product development, and delivering long-term value to customers, employees, and shareholders. These priorities align with INSPECS’s corporate strategy of increasing own-brand penetration, expanding manufacturing capacity, and growing R&D.

Brodie’s expertise in mergers and acquisitions and business integration is particularly relevant given INSPECS’s history of growth through acquisitions. The Board’s focus on these skills suggests inorganic growth remains a strategic consideration. Investors should watch for how Brodie’s commercial and operational experience supports the Group’s expansion and synergy maximization efforts.

Disclosure of City Energy Network Liquidations Highlights Context of Brodie’s Previous Role

The announcement includes AIM Rules disclosure revealing that several entities under Brodie’s directorship at City Energy Network entered creditors' voluntary liquidation or administration in early 2026. These events were linked to the planned cessation of the UK Government’s Energy Company Obligation 4 (ECO4) scheme in December 2026, not to Brodie’s financial management. Entities affected include Consumer Energy Solutions Limited (administration from 9 January 2026) and multiple others in liquidation between 10 and 17 March 2026. The announcement confirms no further disclosures are required under AIM Rules.

Investors will interpret these disclosures within the broader context but are reassured that they relate to external policy changes rather than executive performance.

CEO Richard Peck and Chair Robin Totterman Endorse Brodie’s Appointment Following Rigorous Search

CEO Richard Peck praised Brodie’s extensive financial leadership and strong commercial and operational focus, qualities vital for advancing the Group. Chair Robin Totterman noted the appointment reflects the Board’s commitment to securing the right financial leadership for INSPECS’s next growth phase. Their joint statements emphasize the strategic importance of this hire beyond a simple CFO replacement. Peel Hunt, INSPECS’s Nominated Adviser and Broker, is listed as a contact, consistent with AIM Rules compliance.

INSPECS’s Manufacturing Operations Across Four Countries Amplify CFO’s Financial Management Challenges

Brodie will oversee financial management of manufacturing facilities in Vietnam, China, the UK, and Italy, each with unique regulatory, labor, currency, and supply chain factors. Coordinating capital expenditure, working capital, and financial reporting across these sites and sales offices in multiple regions presents a complex challenge. INSPECS’s plans to expand manufacturing capacity and scale R&D further increase the CFO’s responsibilities. Brodie’s prior experience at Steripack Group provides relevant precedent. Specific capital expenditure and R&D budgets were not disclosed.

Managing a Vast Distribution Network of 75,000 Points of Sale Across 80+ Countries

INSPECS’s extensive distribution network covers over 80 countries and approximately 75,000 retail points, including global retailers, distributors, and independent opticians. The CFO’s role encompasses managing credit risk, foreign exchange, trade receivables, and distributor agreements across this diverse base. Brodie’s M&A and integration expertise is crucial for supporting growth initiatives, including potential acquisitions to broaden distribution or manufacturing capabilities. Investors should monitor upcoming results and strategic updates for insights on capital deployment under Brodie’s leadership.

Global Eyewear Market Trends and INSPECS’s Strategic Focus on Own-Brand Expansion

The eyewear market benefits from structural growth drivers such as aging populations, rising myopia rates, and increasing consumer interest in eyewear as a lifestyle accessory. INSPECS operates across functional and branded segments, with a dual OEM and proprietary brand model. Increasing own-brand sales, which typically yield higher margins, involves marketing investment, brand licensing, and margin management—all areas where CFO input is critical. Brodie’s manufacturing and product-focused commercial background positions him well to navigate these sector dynamics. The company did not provide specific own-brand revenue or margin targets.

Risks for INSPECS Investors Amid CFO Transition and Growth Strategy

Despite the positive governance development of appointing an experienced CFO, investors should consider risks related to INSPECS’s manufacturing footprint in Vietnam, China, the UK, and Italy, including supply chain disruptions, geopolitical tensions, and fluctuating freight and raw material costs. Currency exposure across multiple currencies also poses financial risks. The disclosure of liquidations linked to Brodie’s prior employer underscores the impact of policy changes on regulated sectors, though INSPECS is not directly exposed. Additionally, the Group’s growth via M&A and capacity expansion carries execution risks. The immediate share price reaction to the appointment was not publicly available.